跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Tert-Butyloxycarbonyl Group
首页
药物
Tert-Butyloxycarbonyl Group
Experimental
Small Molecule
Tert-Butyloxycarbonyl Group
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
5
H
10
O
2
UNII ID
J5BC8DA85J
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Method for introducing a 1,2-double bond into 3-oxo-4-azasteroid compounds
US 7872135 B2
申请人: SIEGFRIED LTD
优先权: 2002
US
2 件公开
Pharmaceutical used for treating HIV infection, the composition and uses thereof
US 2006100139 A1
申请人: ZHOU GENFA
优先权: 2005
US
2 件公开
Tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidines as antagonists of serotonin 5-HT6 receptors, methods for the production and use thereof
US 8569318 B2
申请人: IVASHCHENKO ANDREY ALEXANDROVICH
优先权: 2008
US
2 件公开
Process for synthesizing L-N-protective group-azacyclobutane-2-carboxylic acid
CN 1393442 A
申请人: SHANGHAI INST OF MEDICAL MATER
优先权: 2001
CN
Process for the enantioselective enzymatic reduction of intermediates
US 8932835 B2
申请人: GUPTA ANTJE
优先权: 2007
US
PROCESSES FOR PREPARATION OF TAXANES AND INTERMEDIATES THEREOF
US 2009292131 A1
申请人: CVAK LADISLAV
优先权: 2009
US
Method to improve antiviral activity of nucleotide analogue drugs
US 9550803 B2
申请人: MCKENNA CHARLES E
优先权: 2012
US
Preparation methods of 4-(2'-pyridyl)benzyl hydrazine and its intermediate
CN 103483242 A
申请人: SHANGHAI PUYI CHEMICAL CO LTD
优先权: 2012
CN
Preparation method of dasatinib intermediate
CN 104119292 A
申请人: TIANJIN WEIJIE TECHNOLOGY CO LTD
优先权: 2014
CN
Preparation method of doripenem
CN 105254632 A
申请人: HAINAN CHUNTCH PHARMACEUTICAL CO LTD
优先权: 2015
CN
第 1 / 3 页
上一页
下一页
药物
反馈